BIO 2015 Dispatches: Asset Swaps Won't Replace Mega-mergers
This article was originally published in The Pink Sheet Daily
Executive Summary
Business development executives from AstraZeneca, Novartis and Almirall discussed the benefits of assets swaps and if they think mega-mergers are an outdated trend.